Case and Research Letter
Refractory solar urticaria successfully treated with omalizumab with normalization of phototest
Urticaria solar refractaria tratada satisfactoriamente con omalizumab y normalización del fototest
A. Combalia
, C. Fernández-Sartorio, P. Aguilera
Dermatology Department, Hospital Clínic de Barcelona, Barcelona, Spain
Leído
6823
Vecesse ha leído el artículo
2714
Total PDF
4109
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 65 | 34 | 99 |
| 2025 9 | 86 | 23 | 109 |
| 2025 8 | 67 | 37 | 104 |
| 2025 7 | 104 | 17 | 121 |
| 2025 6 | 170 | 27 | 197 |
| 2025 5 | 159 | 37 | 196 |
| 2025 4 | 122 | 29 | 151 |
| 2025 3 | 122 | 21 | 143 |
| 2025 2 | 111 | 40 | 151 |
| 2025 1 | 60 | 36 | 96 |
| 2024 12 | 46 | 24 | 70 |
| 2024 11 | 63 | 54 | 117 |
| 2024 10 | 50 | 52 | 102 |
| 2024 9 | 72 | 24 | 96 |
| 2024 8 | 77 | 52 | 129 |
| 2024 7 | 55 | 29 | 84 |
| 2024 6 | 67 | 49 | 116 |
| 2024 5 | 50 | 39 | 89 |
| 2024 4 | 50 | 22 | 72 |
| 2024 3 | 56 | 27 | 83 |
| 2024 2 | 42 | 29 | 71 |
| 2024 1 | 46 | 20 | 66 |
| 2023 12 | 41 | 22 | 63 |
| 2023 11 | 51 | 33 | 84 |
| 2023 10 | 52 | 23 | 75 |
| 2023 9 | 44 | 26 | 70 |
| 2023 8 | 36 | 12 | 48 |
| 2023 7 | 74 | 27 | 101 |
| 2023 6 | 65 | 20 | 85 |
| 2023 5 | 54 | 27 | 81 |
| 2023 4 | 56 | 27 | 83 |
| 2023 3 | 50 | 26 | 76 |
| 2023 2 | 45 | 30 | 75 |
| 2022 1 | 41 | 30 | 71 |
| 2022 12 | 53 | 31 | 84 |
| 2022 11 | 35 | 30 | 65 |
| 2022 10 | 62 | 29 | 91 |
| 2022 9 | 43 | 43 | 86 |
| 2022 8 | 47 | 46 | 93 |
| 2022 7 | 52 | 35 | 87 |
| 2022 6 | 58 | 26 | 84 |
| 2022 5 | 44 | 52 | 96 |
| 2022 4 | 60 | 39 | 99 |
| 2022 3 | 57 | 39 | 96 |
| 2022 2 | 60 | 26 | 86 |
| 2021 1 | 62 | 40 | 102 |
| 2021 12 | 42 | 32 | 74 |
| 2021 11 | 41 | 45 | 86 |
| 2021 10 | 55 | 62 | 117 |
| 2021 9 | 28 | 35 | 63 |
| 2021 8 | 32 | 36 | 68 |
| 2021 7 | 33 | 35 | 68 |
| 2021 6 | 45 | 48 | 93 |
| 2021 5 | 43 | 57 | 100 |
| 2021 4 | 78 | 83 | 161 |
| 2021 3 | 94 | 29 | 123 |
| 2021 2 | 62 | 36 | 98 |
| 2020 1 | 40 | 38 | 78 |
| 2020 12 | 35 | 19 | 54 |
| 2020 11 | 30 | 34 | 64 |
| 2020 10 | 31 | 34 | 65 |
| 2020 9 | 29 | 29 | 58 |
| 2020 8 | 27 | 26 | 53 |
| 2020 7 | 37 | 21 | 58 |
| 2020 6 | 35 | 30 | 65 |
| 2020 5 | 26 | 12 | 38 |
| 2020 4 | 35 | 19 | 54 |
| 2020 3 | 26 | 16 | 42 |
| 2020 2 | 8 | 0 | 8 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 8 | 0 | 8 |
| 2019 11 | 4 | 0 | 4 |
| 2019 10 | 1 | 0 | 1 |
| 2019 9 | 12 | 0 | 12 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 8 | 0 | 8 |
| 2019 4 | 13 | 0 | 13 |
| 2019 2 | 5 | 0 | 5 |
| 2019 1 | 4 | 2 | 6 |
| 2018 12 | 7 | 2 | 9 |
| 2018 11 | 4 | 2 | 6 |
| 2018 10 | 1 | 0 | 1 |
| 2018 9 | 3 | 0 | 3 |
| 2018 4 | 0 | 1 | 1 |
| 2018 2 | 19 | 6 | 25 |
| 2018 1 | 16 | 10 | 26 |
| 2017 12 | 27 | 12 | 39 |
| 2017 11 | 19 | 12 | 31 |
| 2017 10 | 4 | 15 | 19 |
| 2017 9 | 13 | 18 | 31 |
| 2017 8 | 10 | 52 | 62 |
| 2017 7 | 17 | 228 | 245 |
| 2017 6 | 4 | 25 | 29 |
| 2017 5 | 0 | 7 | 7 |
| 2017 4 | 0 | 29 | 29 |
| 2017 3 | 0 | 21 | 21 |
| 2017 2 | 0 | 35 | 35 |
Mostrar todo
